PD-L1 and IDO1 are Expressed in Poorly-Differentiated Thyroid Carcinoma

BACKGROUND: Poorly differentiated thyroid carcinoma (PDTC) is an aggressive form of thyroid cancer that currently has limited effective treatment options. Immune checkpoint inhibitors (ICIs) have shown to be an effective treatment for a variety of carcinomas. In this study, we explore whether immune...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocr Pathol
Autors principals: Rosenbaum, Matthew W., Gigliotti, Benjamin J., Pai, Sara I., Parangi, Sareh, Wachtel, Heather, Mino-Kenudson, Mari, Gunda, Viswanath, Faquin, William C.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500591/
https://ncbi.nlm.nih.gov/pubmed/29372535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12022-018-9514-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars